LOU SILVERMAN
CIK 1249935 · Chief Executive Officer · last filed 2026-07-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$312.2K
Companies
4
Total Filings
41
Lifetime Open-Market Net
-$6.86M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. (OCX) Delisted | Director | 55,807 | $3.20 | $178.6K | $0 | 5 | 2026-07-06 |
| STAA | Director | 12,658 | $24.64 | $311.9K | -$6.86M | 16 | 2026-06-22 |
| BTX | Director | 38 | $8.98 | $341 | $0 | 4 | 2016-10-31 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | 14,183 | — | — | $0 | 8 | 2013-05-29 |
Recent Filings · Page 4 of 5
41 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-05-14 | QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-05-23 | QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Exer (M) | +10,000 | $41.9K | EDGAR |
| 2011-01-04 | QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-07-16 | QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-06-02 | QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-01-04 | QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-12-11 | QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-06-20 | — | Exer (M) | +42,500 | $821.8K | |
| 2007-06-13 | — | Mixed | +2,700 | -$1.57M | |
| 2007-06-13 | — | Sell (S) | −2,700 | -$103.6K |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.